Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 886372-88-9 | MDL No. : | MFCD07375013 |
Formula : | C6H3BrN2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DBDUQNAKRDIQJF-UHFFFAOYSA-N |
M.W : | 215.07 | Pubchem ID : | 51063942 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 45.12 |
TPSA : | 54.02 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.96 cm/s |
Log Po/w (iLOGP) : | 1.91 |
Log Po/w (XLOGP3) : | 2.33 |
Log Po/w (WLOGP) : | 2.45 |
Log Po/w (MLOGP) : | 1.01 |
Log Po/w (SILICOS-IT) : | 3.4 |
Consensus Log Po/w : | 2.22 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.31 |
Solubility : | 0.106 mg/ml ; 0.000493 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.1 |
Solubility : | 0.169 mg/ml ; 0.000788 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.46 |
Solubility : | 0.0753 mg/ml ; 0.00035 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.22 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate; In toluene; at 100.0℃; for 1.5h;Inert atmosphere; | Example lb - Preparation of R2 groupPreparation of Thiazolo[5,4-b]pyridin-6-ol: 6-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)thiazolo[5,4-b]pyridine: A round bottom flask was charged with <strong>[886372-88-9]6-bromothiazolo[5,4-b]pyridine</strong> (430mg, 2.00 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(l,3,2-dioxaborolane) (660 mg, 2.6mmol), KOAc (392mg, 4.00 mmol), toluene (10 ml), vacuum flushed with nitrogen (3x), and treated with PdCl2dppf (82 mg, 0.100 mmol), vacuum flushed (3x), and placed in a 100 C oil bath. After 1.5h reaction was complete by LCMS. Work-up: filtered, concentrated, and purified by flash chromatography (5-95% EtOAc/Hex). 610 mg (116%) of colorless oil was obtained, that was contaminated boron derived side products. This material was used in the next step without further purification. [0258] Thiazolo[5,4-b]pyridin-6-ol: To a solution of 6-(4,4,5,5-tetramethyl- l,3,2-dioxaborolan-2-yl)thiazolo[5,4-b]pyridine (524 mg, 2.0 mmol), dissolved in acetone (10 ml), was added a solution of Oxone (0.2M, 10 mL, 2.0 mmol), at room temperature. LCMS showed dissapearance of all starting material after lOmin. Work-up: the reaction was acidified with IN HCl, extracted with ether (5x25 mL), dried of Na2SC>4, and purified by PvPLC. Yield of yellow powder was 48mg (16%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
10% | With tris-(dibenzylideneacetone)dipalladium(0); dicyclohexyl-(2?,4?,6?-triisopropyl-3,6-dimethoxy-[1,1?-biphenyl]-2-yl)phosphine; caesium carbonate; In 1,4-dioxane; at 100.0℃; for 16.0h;Inert atmosphere; | A mixture of l-(3-amino-5-methyl-5H-chromeno[4,3-c]pyridin-8-yl)pynOlidin-2- one (100 mg, 0.339 mmol), <strong>[886372-88-9]6-bromothiazolo[5,4-b]pyridine</strong> (109 mg, 0.508 mmol), Pd2(dba)3 (31 mg, 0.034 mmol), BrettPhos (36 mg, 0.068 mmol) and CS2CO3 (221 mg, 0.677 mmol) in anhydrous dioxane (3 mL) was degassed and purged with N2 for 3 times. Then the resulting reaction mixture was heated at 100 C for 16 h under N2 atmosphere. The reaction mixture turned into yellow suspension from red. Crude LCMS (Rt = 0.750 min; MS Calcd: 429.1 ; MS Found: 430.0 [M+H]+). To the reaction mixture was added water (25 mL), then extracted with EtOAc/THF (25 mL x3, 1/1). The combined organic layer was washed with brine (25 mL), dried over anhydrous Na2S04 and concentrated. The residue was purified by prep-HPLC (0.225% FA as an additive). Most of the MeCN was removed under reduced pressure and the remaining part was lyophilized to give the product, which was further triturated with MeCN (3 mL), then filtered and washed with MeCN (0.5 mL x2) and lyophilized to give l-(5-methyl-3- (thiazolo[5,4-b]pyridin-6-ylamino)-5H-chromeno[4,3-c]pyridin-8-yl)pyrrolidin-2-one (14.2 mg, yield: 10%) as a yellow solid. (0999) [0384] LCMS was taken on a quadrupole Mass Spectrometer on Shimadzu LCMS 2010 (Shim-pack XR-ODS 3.0*30 mm 2.2 pm) operating in ES (+) ionization mode. Flow Rate: 0.8 mL/min, Acquire Time: 3 min, Wavelength: UV220, Oven Tern.: 50 C, Mobile phase: from 90% [water + 0.04% TFA] and 10% [MeCN +0.02 % TFA] to 20% [water + 0.04% TFA] and 80% [MeCN + 0.02% TFA] in 1.35 min, then under this condition for 0.9 min, finally changed to 90% [water + 0.04% TFA] and 10% [MeCN + 0.02% TFA] and under this condition for 0.75 min. purity is 99.80%, Rt = 1.400 min; MS Calcd.: 429.1, MS Found: 430.0 [M+H]+. (1000) NMR (400 MHz, DMSO-r e) d 1.56 (3H, d, J= 6.4 Hz), 2.01-2.10 (2H, m), 2.52-2.54 (2H, m), 3.80-3.90 (2H, m), 5.31 (1H, q, J= 6.4 Hz), 6.79 (1H, s), 7.33 (1H, dd, J= 8.7, 2.1 Hz), 7.42 (1H, d, J= 2.0 Hz), 7.91 (1H, d, J= 8.8 Hz), 8.76 (1H, s), 8.79 (1H, d, J= 2.5 Hz), 9.14 (1H, d, J= 2.5 Hz), 9.50 (1H, s), 9.78 (1H, brs). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With trifluoromethylsulfonic anhydride; [bis(acetoxy)iodo]benzene; iodine; In water; at 110℃; for 6h;Sealed tube; Green chemistry; | General procedure: To a 35 mL sealed tube was added benzo[d]thiazole 1a (0.2 mmol), KSeCN (43.2 mg, 0.3 mmol), I2 (10.2 mg, 20 mol %), PIDA (96.6 mg, 1.5 equiv) and Tf2O (0.8 equiv)in H2O (3 mL) under air. The reaction was heated at 110 oC for 6 h (oil bath), and then cooled down to room temperature. Ethyl acetate (20 mL) was added and the mixture was washed with water (3 × 10 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated. The residue was purified by preparative TLC on silica gel plates using petroleum ether/EtOAc = 3/1 as the eluent to give the corresponding product 2a. |
[ 886372-92-5 ]
6-Bromo-2-methylthiazolo[5,4-b]pyridine
Similarity: 0.99
[ 1160791-13-8 ]
2-Amino-6-bromothiazolo[5,4-b]pyridine
Similarity: 0.87
[ 412923-40-1 ]
2-Bromothiazolo[5,4-b]pyridine
Similarity: 0.75
[ 934266-82-7 ]
5-Bromothiazolo[5,4-b]pyridin-2-amine
Similarity: 0.69
[ 886372-92-5 ]
6-Bromo-2-methylthiazolo[5,4-b]pyridine
Similarity: 0.99
[ 1160791-13-8 ]
2-Amino-6-bromothiazolo[5,4-b]pyridine
Similarity: 0.87
[ 412923-40-1 ]
2-Bromothiazolo[5,4-b]pyridine
Similarity: 0.75
[ 934266-82-7 ]
5-Bromothiazolo[5,4-b]pyridin-2-amine
Similarity: 0.69